Treatment of Lupus Dermatitis
Hydroxychloroquine is the first-line systemic treatment for lupus dermatitis, combined with topical corticosteroids for localized lesions. 1, 2
First-Line Treatments
Topical Therapies
Super-potent topical corticosteroids:
Topical calcineurin inhibitors (tacrolimus 0.1%):
Systemic Therapies
- Hydroxychloroquine:
Adjunctive Measures
Sun protection:
Smoking cessation:
- Strongly recommended as smoking reduces treatment efficacy 2
Second-Line Treatments
For Refractory Cases
Azathioprine:
Mycophenolate mofetil:
Methotrexate:
Treatment Algorithm
Mild localized disease:
- Topical corticosteroids (clobetasol 0.05%) twice daily
- Topical calcineurin inhibitors for face/sensitive areas
- Sun protection measures
Moderate to severe or widespread disease:
- Add hydroxychloroquine 200-400 mg daily
- Continue topical treatments for localized lesions
- Reassess after 2-3 months (full effect may take time)
Refractory disease (inadequate response after 3 months):
- Add or switch to azathioprine, mycophenolate mofetil, or methotrexate
- Consider short-term systemic corticosteroids for acute flares
- For severe refractory cases, consider biologics like belimumab 2
Monitoring
- Regular skin examinations to assess treatment response
- Monitor for medication side effects (ophthalmologic exams for hydroxychloroquine, liver function tests for azathioprine/methotrexate)
- Assess for development of systemic symptoms
Common Pitfalls
- Inadequate sun protection: Failure to emphasize photoprotection can lead to treatment failure
- Insufficient treatment duration: Antimalarials require weeks to months for full effect
- Overuse of topical steroids: Can lead to skin atrophy and telangiectasia
- Missing systemic disease: Cutaneous lupus can progress to systemic disease in 12-18% of cases 8